Published on in Vol 25 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/49771, first published
.
![Potential and Limitations of ChatGPT 3.5 and 4.0 as a Source of COVID-19 Information: Comprehensive Comparative Analysis of Generative and Authoritative Information Potential and Limitations of ChatGPT 3.5 and 4.0 as a Source of COVID-19 Information: Comprehensive Comparative Analysis of Generative and Authoritative Information](https://asset.jmir.pub/assets/0599d270111e96403dd1c7f2b01fe1f2.png 480w,https://asset.jmir.pub/assets/0599d270111e96403dd1c7f2b01fe1f2.png 960w,https://asset.jmir.pub/assets/0599d270111e96403dd1c7f2b01fe1f2.png 1920w,https://asset.jmir.pub/assets/0599d270111e96403dd1c7f2b01fe1f2.png 2500w)
Journals
- Marshall R, Mallem K, Xu H, Thorne J, Burkholder B, Chaon B, Liberman P, Berkenstock M. Investigating the Accuracy and Completeness of an Artificial Intelligence Large Language Model About Uveitis: An Evaluation of ChatGPT. Ocular Immunology and Inflammation 2024:1 View
- Meo S, Alotaibi M, Meo M, Meo M, Hamid M. Medical knowledge of ChatGPT in public health, infectious diseases, COVID-19 pandemic, and vaccines: multiple choice questions examination based performance. Frontiers in Public Health 2024;12 View
- Li K, Fernandez A, Schwartz R, Rios N, Carlisle M, Amend G, Patel H, Breyer B. Comparing GPT-4 and Human Researchers in Qualitative Analysis of Healthcare Data: Qualitative Description Study (Preprint). Journal of Medical Internet Research 2024 View